Philip Beachy, professor of urology and of developmental biology at the Stanford University School of Medicine, has been awarded the Bladder Cancer Advocacy Network Bladder Cancer Research Innovation Award.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
